Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott pays $5.5m to settle US kickback allegations

This article was originally published in Clinica

Executive Summary

The US Department of Justice’s efforts to clamp down on fraudulent behavior by healthcare companies continue, with Abbott the latest to be caught out – the company has just agreed to pay $5.475m to resolve allegations that it had paid kickbacks to doctors. The DoJ alleged that the firm paid prominent physicians for teaching assignments, speaking engagements and conferences “with the expectation that these physicians would arrange for the hospitals with which they were affiliated to purchase Abbott’s carotid, biliary and peripheral vascular products.” The claims were originally made by ex-Abbott employees Steven Peters and Douglas Gray, who will receive over $1m as part of the latest agreement.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT101218

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel